Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Veracyte: Q4 Earnings Snapshot

Veracyte: Q4 Earnings Snapshot

VCYT : 19.33 (+0.68%)
Veracyte: Q3 Earnings Snapshot

Veracyte: Q3 Earnings Snapshot

VCYT : 19.33 (+0.68%)
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?

The genetic test maker is rapidly increasing test volumes.

AZN : 68.61 (+0.37%)
COMP : 3.21 (-1.53%)
VCYT : 19.33 (+0.68%)
Veracyte: Q2 Earnings Snapshot

Veracyte: Q2 Earnings Snapshot

VCYT : 19.33 (+0.68%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

/PRNewswire/ -- USA News Group - With this year's Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there's...

ONC.TO : 1.42 (-0.70%)
ONCY : 1.0300 (unch)
JAZZ : 110.12 (+0.78%)
GERN : 3.71 (-0.54%)
INAB : 1.0200 (-2.86%)
VCYT : 19.33 (+0.68%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END

ONCY : 1.0300 (unch)
ONC.TO : 1.42 (-0.70%)
JAZZ : 110.12 (+0.78%)
GERN : 3.71 (-0.54%)
INAB : 1.0200 (-2.86%)
VCYT : 19.33 (+0.68%)
Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023

USA News Group – With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there’s plenty of anticipation for updates on some of the biggest...

ONCY : 1.0300 (unch)
ONC.TO : 1.42 (-0.70%)
JAZZ : 110.12 (+0.78%)
GERN : 3.71 (-0.54%)
INAB : 1.0200 (-2.86%)
VCYT : 19.33 (+0.68%)
Here's Why This Little-Known Growth Stock Is a Buy

Analysts think this genomic test maker could have major upside in the next year.

VCYT : 19.33 (+0.68%)
A New Groundbreaking Tool to Detect Colon Cancer Earlier

A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This discovery...

MYNZ : 0.9066 (+0.29%)
EXAS : 60.89 (-4.08%)
GH : 16.03 (-3.84%)
VCYT : 19.33 (+0.68%)
HOLX : 75.11 (+0.01%)
Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 21.43% and 6.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VCYT : 19.33 (+0.68%)
MASS : 5.68 (+1.43%)

Barchart Exclusives

Up 67% YTD, Is Soundhound AI Overvalued?
Soundhound AI's shares have surged, thanks to Nvidia's investment in the company and growing enthusiasm surrounding AI. After a steep pullback, is the stock still overvalued? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar